Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure

Status unconfirmed

Conditions studied: Colon Cancer

In brief

This is a study whose focus is on understanding the clinical utility of rectal ultrastructure in detecting colonic neoplasm. The method uses Low-coherence Enhanced Backscattering Spectroscopy (LEBS).

Key facts

Study ID

NCT02730702

Run by

American BioOptics, LLC

People needed

600

Starts

2016-09-01

Expected to finish

2020-09-01

Last updated by the study team

2018-08-01

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects are eligible if they were scheduled for colonoscopy for colon cancer screening or surveillance

You may not qualify if…

• age <50
• personal/family history of colonic neoplasia
• personal history of coagulopathy
• (retrospectively) failure to complete or inadequate colonoscopy
• any patients harboring non-pathoglocially normal rectum (i.e. presence of lesion, inflammation, polyp, adenomas at rectum)

Where it is running

• Boston Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.